Europe Pharmacovigilance and Drug Safety Software Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Offering (Software and Services), Deployment (Cloud and On-Premises), Enterprise Size (Large Enterprises and SMEs), Form (Standard and Customized), Functionality (Signal and Risk Management, Issue Tracking and Adverse Event Tracking, Case Management, Clinical Safety Management and Clinical Trial Safety, Quality and Compliance, Medical Writing, Audit Support and Training Compliance, Healthcare Analytics, and Others), End User [Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing (BPO) Firms, and Others], and Country

No. of Pages: 205    |    Report Code: TIPRE00022771    |    Category: Technology, Media and Telecommunications

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Pharmacovigilance and Drug Safety Software Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Pharmacovigilance and Drug Safety Software Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rise In Incidences of Adverse Drug Reactions
  • 5.1.2 Globalization of Pharmacovigilance
  • 5.1.3 Surge in Drug Development Rates
5.2 Market Opportunities
  • 5.2.1 Integration of Software with AI, ML, and NLP
5.3 Future Trends
  • 5.3.1 Cloud-Based Pharmacovigilance and Drug Safety Software
5.4 Impact of Drivers and Restraints

6. Europe Pharmacovigilance and Drug Safety Software Market Regional Analysis

6.1 Europe Pharmacovigilance and Drug Safety Software Market Overview
6.2 Europe Pharmacovigilance and Drug Safety Software Market Revenue 2021-2031 (US$ Million)
6.3 Europe Pharmacovigilance and Drug Safety Software Market Forecast Analysis

7. Europe Pharmacovigilance and Drug Safety Software Market Analysis – by Offering

7.1 Software
  • 7.1.1 Overview
  • 7.1.2 Software: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Services
  • 7.2.1 Overview
  • 7.2.2 Services: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Pharmacovigilance and Drug Safety Software Market Analysis – by Deployment

8.1 Cloud
  • 8.1.1 Overview
  • 8.1.2 Cloud: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
8.2 On-Premises
  • 8.2.1 Overview
  • 8.2.2 On-Premises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

9. Europe Pharmacovigilance and Drug Safety Software Market Analysis – by Enterprise Size

9.1 Large Enterprises
  • 9.1.1 Overview
  • 9.1.2 On-Premises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
9.2 SMEs
  • 9.2.1 Overview
  • 9.2.2 On-Premises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

10. Europe Pharmacovigilance and Drug Safety Software Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Country, 2024 and 2031 (%)
  • 10.1.1.1 Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.1.1 UK: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
    • 10.1.1.1.2 UK: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
    • 10.1.1.1.3 UK: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
  • 10.1.1.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
    • 10.1.1.2.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
    • 10.1.1.2.3 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
  • 10.1.1.3 France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.3.1 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
    • 10.1.1.3.2 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
    • 10.1.1.3.3 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
  • 10.1.1.4 Russia: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
    • 10.1.1.4.2 Russia: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
    • 10.1.1.4.3 Russia: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
  • 10.1.1.5 Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
    • 10.1.1.5.2 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
    • 10.1.1.5.3 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
  • 10.1.1.6 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
    • 10.1.1.6.2 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
    • 10.1.1.6.3 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Pharmacovigilance and Drug Safety Software Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 ArisGlobal LLC
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Max Application
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Oracle Corp
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Veeva Systems Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 IQVIA Holdings Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 ICON Plc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Cognizant Technology Solutions Corp
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Accenture Plc
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Syneos Health Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Genpact Ltd.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 AB Cube S.A.S.
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
13.12 Laboratory Corp of America Holdings
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
13.13 Parexel International Corp
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
13.14 Qinecsa Solutions
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
13.15 Clinevo Technologies
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  • ArisGlobal LLC     
  • Max Application    
  • Oracle Corp         
  • Veeva Systems Inc           
  • IQVIA Holdings Inc           
  • ICON Plc             
  • Cognizant Technology Solutions Corp       
  • Accenture Plc      
  • Syneos Health Inc            
  • Genpact Ltd.        
  • AB Cube S.A.S.    
  • Laboratory Corp of America Holdings        
  • Parexel International Corp            
  • Qinecsa Solutions            
  • Clinevo Technologies
europe-pharmacovigilance-and-drug-safety-software-market